LyondellBasell Acquires Mepol Group for Advanced Polymer Solutions

LyondellBasell, a global leader in polymer and polyolefin technologies, has successfully acquired Mepol Group, a manufacturer of high-performing recycled compounds based in Italy and Poland.

The acquisition aligns with LyondellBasell's commitment to the circular economy and provides significant growth opportunities in the Advanced Polymer Solutions (APS) business unit. Mepol and all its subsidiaries will now be subsidiaries of LyondellBasell's APS segment, leveraging Mepol's expertise in recycled compounds and LyondellBasell's strategy and scale. 

Torkel Rhenman, executive vice president of Advanced Polymer Solutions of LyondellBasell said, "With Mepol's deep expertise in recycled compounds and LyondellBasell's strategy and scale, we see significant opportunities to accelerate the growth of our APS business by leveraging macro trends in circularity and creating solutions for everyday sustainable living."

The company aims to create sustainable solutions for everyday living while meeting the increasing demand for circular and renewable products. By 2030, LyondellBasell plans to produce and market at least 2 million metric tons of polymers from recycled or renewable-based sources annually.

The Wesseling, Germany, complex is LyondellBasells largest manufacturing...
The Wesseling, Germany, complex is LyondellBasell's largest manufacturing facility in Europe. © LyondellBasell

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.